Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration

BACKGROUND: Parkinson’s disease (PD) is the second most common neurodegenerative disease, presenting with midbrain dopaminergic neurons degeneration. A number of studies suggest that microglial activation may have a role in PD. It has emerged that inflammation-derived oxidative stress and cytokine-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Carelli, Stephana, Giallongo, Toniella, Gombalova, Zuzana, Rey, Federica, Gorio, Maria Carlotta F., Mazza, Massimiliano, Di Giulio, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271641/
https://www.ncbi.nlm.nih.gov/pubmed/30501635
http://dx.doi.org/10.1186/s12974-018-1375-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271641/
https://www.ncbi.nlm.nih.gov/pubmed/30501635
http://dx.doi.org/10.1186/s12974-018-1375-2

Ejemplares similares